U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H14NO.Br
Molecular Weight 220.107
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FURTRETHONIUM BROMIDE

SMILES

[Br-].C[N+](C)(C)CC1=CC=CO1

InChI

InChIKey=BXGSZEWYYLFSEJ-UHFFFAOYSA-M
InChI=1S/C8H14NO.BrH/c1-9(2,3)7-8-5-4-6-10-8;/h4-6H,7H2,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI

Description

FURTRETHONIUM is an agonist of muscarinic acetylcholine receptors. It was used for the treatment of glaucoma.

Approval Year

1944
15

Conditions

ConditionModalityTargetsHighest PhaseProduct
Glaucoma
57
 Primary
Approved
8,429
Furmethide

Doses

AEs

Sourcing

PubMed

Patents

JP2002105045A
7
ACTIVE MOIETY
Structure of FURTRETHONIUM
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966